175 related articles for article (PubMed ID: 34644228)
1. Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism.
Reed S; Koro C; DiBello J; Becker K; Bauerfeind A; Franke C; Heinemann K
Eur J Contracept Reprod Health Care; 2021 Dec; 26(6):439-446. PubMed ID: 34644228
[TBL] [Abstract][Full Text] [Related]
2. Unintended pregnancy in users of nomegestrol acetate and 17β-oestradiol (NOMAC-E2) compared with levonorgestrel-containing combined oral contraceptives: final results from the PRO-E2 study.
Reed S; Koro C; DiBello J; Becker K; Bauerfeind A; Franke C; Heinemann K
Eur J Contracept Reprod Health Care; 2021 Dec; 26(6):447-453. PubMed ID: 34651535
[TBL] [Abstract][Full Text] [Related]
3. Is the multinational, surveillance PRO-E2 study informative for all countries? The Italian data on VTE and contraceptive effectiveness.
Fruzzetti F; Cagnacci A; Boolell M; Di Carlo C; Bruni V
Eur J Contracept Reprod Health Care; 2024 Feb; 29(1):1-7. PubMed ID: 38085301
[TBL] [Abstract][Full Text] [Related]
4. NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study.
von Stockum S; Becker K; Bauerfeind A; Franke C; Fruzzetti F; Calaf J; Keck C; Heinemann K
Gynecol Endocrinol; 2023 Dec; 39(1):2166032. PubMed ID: 36690019
[TBL] [Abstract][Full Text] [Related]
5. NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study.
von Stockum S; Bauerfeind A; Becker K; Franke C; Fruzzetti F; Calaf J; Keck C; Heinemann K
Gynecol Endocrinol; 2023 Dec; 39(1):2162036. PubMed ID: 36617423
[No Abstract] [Full Text] [Related]
6. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
Gaussem P; Alhenc-Gelas M; Thomas JL; Bachelot-Loza C; Remones V; Ali FD; Aiach M; Scarabin PY
Thromb Haemost; 2011 Mar; 105(3):560-7. PubMed ID: 21225090
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States.
Kaplan S; Bertoia ML; Wang FT; Zhou L; Lass A; Evans A; Dhanda S; Roy D; Seeger JD
Contraception; 2022 Jan; 105():26-32. PubMed ID: 34599911
[TBL] [Abstract][Full Text] [Related]
8. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism.
Ågren UM; Anttila M; Mäenpää-Liukko K; Rantala ML; Rautiainen H; Sommer WF; Mommers E
Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):444-57. PubMed ID: 22066891
[TBL] [Abstract][Full Text] [Related]
9. Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17β-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women.
Mansour D; Westhoff C; Kher U; Korver T
Contraception; 2017 Apr; 95(4):390-397. PubMed ID: 28011288
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea.
Grandi G; Napolitano A; Xholli A; Tirelli A; Di Carlo C; Cagnacci A
Gynecol Endocrinol; 2015 Oct; 31(10):774-8. PubMed ID: 26291811
[TBL] [Abstract][Full Text] [Related]
11. Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β-estradiol in comparison to levonorgestrel/ethinylestradiol.
Sørdal T; Grob P; Verhoeven C
Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1279-85. PubMed ID: 22762147
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.
Mansour D; Verhoeven C; Sommer W; Weisberg E; Taneepanichskul S; Melis GB; Sundström-Poromaa I; Korver T
Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):430-43. PubMed ID: 21995590
[TBL] [Abstract][Full Text] [Related]
13. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
14. Nomegestrol acetate, a novel progestogen for oral contraception.
Mueck AO; Sitruk-Ware R
Steroids; 2011 May; 76(6):531-9. PubMed ID: 21335021
[TBL] [Abstract][Full Text] [Related]
15. The effect of therapeutic and supratherapeutic oral doses of nomegestrol acetate (NOMAC)/17β-estradiol (E2) on QTcF intervals in healthy women: results from a randomized, double-blind, placebo- and positive-controlled trial.
de Kam PJ; van Kuijk J; Lillin O; Post T; Thomsen T
Clin Drug Investig; 2014 Jun; 34(6):413-20. PubMed ID: 24777591
[TBL] [Abstract][Full Text] [Related]
16. Prediction of nomegestrol acetate pharmacokinetics in healthy female adolescents and adults by whole-body physiology-based pharmacokinetic modelling and clinical validation.
Post TM; Gerrits M; Kerbusch T; de Greef R
Contraception; 2016 Feb; 93(2):133-8. PubMed ID: 26365792
[TBL] [Abstract][Full Text] [Related]
17. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function.
Ågren UM; Anttila M; Mäenpää-Liukko K; Rantala ML; Rautiainen H; Sommer WF; Mommers E
Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):458-67. PubMed ID: 21942708
[TBL] [Abstract][Full Text] [Related]
18. Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
Bauerfeind A; von Stockum S; Boehnke T; Heinemann K
Obstet Gynecol; 2024 Mar; 143(3):431-434. PubMed ID: 38227942
[TBL] [Abstract][Full Text] [Related]
19. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
20. Treatment continuation and satisfaction in women using combined oral contraception with nomegestrol acetate and oestradiol: a multicentre, prospective cohort study (BOLERO).
Cagnacci A; Bastianelli C; Neri M; Cianci A; Benedetto C; Calanni L; Vignali M; De Leo V; Cicinelli E; Borrelli G; Volpe A;
Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):393-399. PubMed ID: 30465698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
